Welcome to our dedicated page for Hillenbrand SEC filings (Ticker: HI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hillenbrand Inc. filings document the company's industrial business disclosures, merger-related material events, and subsequent changes to its public-company status. Recent 8-K reports cover operating and financial results, material agreements, shareholder voting matters, Regulation FD disclosures, senior-note change-of-control offers, and capital-structure information tied to its common stock and outstanding senior notes.
The filing record also includes Form 25 and Form 15 filings that document the removal of Hillenbrand common stock from New York Stock Exchange listing and registration, and the termination or suspension of Exchange Act reporting obligations for its common stock and senior notes due 2029 and 2031. The merger record states that Hillenbrand survived as a wholly owned subsidiary of an affiliate of Lone Star.
Kimberly K. Ryan, listed as President & CEO and a Director of Hillenbrand, Inc. (HI), reported transactions with an earliest transaction date of 09/30/2025. The filing shows a reported disposition of 175,565.745 shares of common stock (Code V), reducing her direct holdings. On the same date she acquired several restricted stock unit awards that convert into common shares: 83, 237, 432, and 312 RSUs, which correspond to 10,116, 28,788, 52,423, and 37,829 shares beneficially owned following each reported award, respectively. Vesting schedules and the matching RSU framework are disclosed in the filing.
Dennis W. Pullin, a director of Hillenbrand, Inc. (HI), reported acquisitions of restricted stock units on 09/30/2025. The Form 4 shows five separate deferred restricted stock unit awards tied to grant dates of 5/7/21, 2/10/22, 2/24/23, 2/20/24, and 2/18/25, resulting in additions of 9, 23, 24, 26, and 34 units respectively (totaling 116 RSUs). Each RSU represents the right to receive one share and carries dividend equivalent rights. The RSUs vest on the earlier of the next annual meeting or one year from grant but accelerate upon a change in control, the director’s death or permanent disability, or one day after the director ceases to be a director. The filing was signed by an attorney-in-fact on 10/02/2025.
Joy M. Greenway, a director of Hillenbrand, Inc. (HI), was awarded a series of Restricted Stock Units on 09/30/2025. The Form 4 reports the acquisition of 368 RSUs across awards dated 2013–2025 (individual grant amounts: 21, 33, 33, 38, 27, 24, 24, 36, 25, 23, 24, 26, 34). Each RSU represents the right to one share and the awards carry dividend equivalent rights; the reported per-share price is $0 because these are compensation awards rather than market purchases.
The filing notes vesting rules: some older awards vest immediately but have post-service holding requirements, while more recent awards vest at the next annual meeting or one year from grant and include accelerated vesting on a change in control, death, or disability. The Form 4 was filed by an attorney-in-fact on behalf of Ms. Greenway and shows these transactions were reported as acquisitions of derivative securities that convert into common stock.
Carole Anne Phillips, Senior Vice President & Chief Procurement Officer of Hillenbrand, Inc. (HI), reported changes in beneficial ownership on 09/30/2025. The Form 4 shows the acquisition (settlement) of multiple Restricted Stock Units (RSUs): 4 RSUs from a 12/07/2022 award (bringing that award's underlying common stock total to 578 shares), 13 RSUs from a 12/07/2023 award (total 1,629 shares), 23 RSUs from a 12/05/2024 award (total 2,824 shares), and 23 Matching RSUs under the Executive Share Match framework (listed as 2,788 underlying shares). Each RSU represents the contingent right to one share and RSUs carry dividend equivalence where noted. The filing was signed by an attorney-in-fact on 10/02/2025.
Helen W. Cornell, a director of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows indirect beneficial ownership of 11,691 shares held by the Helen W. Cornell 2020 Irrevocable Trust and 1,500 shares held by the Helen W. Cornell Rev. Trust. On 09/30/2025 Ms. Cornell was credited with 490 Restricted Stock Units (RSUs) across awards dating from 2012 through 2025. Several RSU grants vest immediately or under short schedules and carry dividend-equivalent rights; vesting and share delivery are subject to the issuer’s holding rules and specified conditions such as the next annual meeting or one year from grant for certain awards. The form is signed by an attorney-in-fact on 10/02/2025.
Hillenbrand director Inderpreet Sawhney reported receipt of restricted stock units on 09/30/2025. The filing lists five deferred stock awards totaling 114 Restricted Stock Units (7, 23, 24, 26, and 34 units). Each unit represents a contingent right to one share of common stock and carries dividend equivalent rights. The units have zero purchase price and vest on the earlier of the next annual meeting or one year from grant, with immediate vesting if a change in control, the director's death or disability, or the director’s termination occurs.
Insider transactions by Tamara Morytko, Sr. VP & President, MTS at Hillenbrand, Inc. (HI) show restricted stock units vesting and a partial sale of common stock on 09/11/2025. 4,245 Restricted Stock Units (granted 09/11/2023) were recorded as acquired/vested with a $0 per-share conversion value and dividend-equivalent rights. On the same date, 1,997 shares of common stock were disposed of at $25.365 per share. Post-transaction beneficial ownership figures in the filing are presented as 7,668 and 5,671 shares in the non-derivative table and 8,498 shares in the derivative table reflecting RSU holdings. The form is signed by an Attorney-in-Fact on 09/15/2025.
Insider transactions by Tamara Morytko, Sr. VP & President, MTS at Hillenbrand, Inc. (HI) show restricted stock units vesting and a partial sale of common stock on 09/11/2025. 4,245 Restricted Stock Units (granted 09/11/2023) were recorded as acquired/vested with a $0 per-share conversion value and dividend-equivalent rights. On the same date, 1,997 shares of common stock were disposed of at $25.365 per share. Post-transaction beneficial ownership figures in the filing are presented as 7,668 and 5,671 shares in the non-derivative table and 8,498 shares in the derivative table reflecting RSU holdings. The form is signed by an Attorney-in-Fact on 09/15/2025.
Hillenbrand, Inc. Schedule 13G/A discloses that a group including Clarkston Capital Partners, Clarkston Companies, Modell Capital and certain individuals beneficially own 3,346,801 shares of Hillenbrand common stock, representing 4.74% of 70,482,047 shares outstanding. The filing provides a clear allocation of voting and dispositive power: 1,267,500 shares with sole voting/dispositive power, 2,069,451 shares with shared voting power and 2,079,301 shares with shared dispositive power.
The statement notes the shares were purchased by Clarkston Capital Partners on behalf of discretionary clients or held by a control person in accounts and that the holdings were acquired in the ordinary course of business and are not held to change or influence control. A joint filing agreement among the reporting persons is attached as an exhibit.
Hillenbrand, Inc. reported revenue compression for the quarter and year-to-date as the company re-shaped its portfolio through divestitures. Net revenue for the three months ended June 30, 2025 was $598.9 million, down from $786.6 million a year earlier; nine-month revenue was $2,021.7 million versus $2,345.2 million. Gross profit declined to $202.6 million for the quarter.
The company recorded positive consolidated net income of $4.1 million for the quarter (income attributable to Hillenbrand of $1.9 million, or $0.03 per share) compared with a large loss in the prior-year quarter. For the nine months, consolidated net loss was $25.6 million. Hillenbrand completed the March 31, 2025 divestiture of a majority interest in Milacron, receiving total consideration of $286.0 million (comprised of $98.0 million cash and $188.0 million of debt assumed by the buyer), recorded an initial equity method investment of $68.7 million, and recognized a loss on divestiture of $56.1 million year-to-date. In a subsequent event, Hillenbrand sold its TerraSource interest on July 1, 2025 for $245.0 million and expects a pre-tax gain of approximately $66.0 million, subject to adjustments. Total assets declined to $4,676.5 million and total liabilities to $3,324.3 million at June 30, 2025.
Hillenbrand, Inc. announced its earnings for the third quarter ended June 30, 2025 and furnished a press release as Exhibit 99.1 to this Form 8-K. The company will sponsor a conference call and simultaneous webcast at 8 a.m. EST on August 12, 2025, accessible on the company’s investor site at http://ir.hillenbrand.com.
The filing notes that the information furnished, including exhibits, is not deemed to be “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated. The report is signed on behalf of the registrant by Megan A. Walke, Interim Chief Financial Officer and Corporate Controller.